BILIARY TRACT CANCER (BTC)
Clinical trials for BILIARY TRACT CANCER (BTC) explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER (BTC) trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER (BTC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer: drug combo aims to extend life
Disease control Not yet recruitingThis study tests whether adding the experimental drug D07001 to standard chemotherapy (capecitabine) helps people with advanced biliary tract cancer live longer. About 195 adults whose cancer has not responded to previous treatments will receive either D07001 or a placebo, plus c…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE3 • Sponsor: InnoPharmax Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo aims to boost survival in tough bile duct cancer
Disease control Not yet recruitingThis study tests whether adding the drug Mitazalimab to standard chemotherapy helps people with advanced bile duct cancer live longer. About 160 adults whose cancer has spread or cannot be removed will take part. They will receive either chemo alone or chemo plus Mitazalimab, and…
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: PHASE2, PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Herbal pill may boost Well-Being in advanced bile duct cancer
Symptom relief Not yet recruitingThis study tests whether adding Yueju Pill, a traditional Chinese herbal medicine, to standard cancer treatment can improve quality of life for people with advanced biliary tract cancer. About 210 adults with this cancer will receive either the pill or a placebo, and researchers …
Matched conditions: BILIARY TRACT CANCER (BTC)
Phase: NA • Sponsor: Fudan University • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Old tumor samples may hold key to future biliary cancer treatments
Knowledge-focused Not yet recruitingThis study will examine stored tumor samples from 244 people diagnosed with biliary tract cancer in the last 15 years. Researchers will measure five specific markers (CLDN18.2, HER2, TROP2, PD-L1, and B7-H4) to see how they relate to patient outcomes. The goal is to better group …
Matched conditions: BILIARY TRACT CANCER (BTC)
Sponsor: MedSIR • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC
-
Can simple blood tests predict bile duct cancer outcomes?
Knowledge-focused Not yet recruitingThis study looks at whether blood tests that detect cancer DNA (ctDNA) and patient-reported quality of life can help predict how bile duct cancer will progress and how well treatment is working. Researchers will collect blood samples and questionnaires from 300 patients with cura…
Matched conditions: BILIARY TRACT CANCER (BTC)
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated May 07, 2026 18:40 UTC